Desensitization and drug habituation in HIV-positive subjects;Desensibilisation et accoutumance medicamenteuse chez le sujet VIH

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 38, Issue 4, 1998, Pages 385-389

  Demoly, P ^a   Messaad, D ^a   Sahla, H ^a   Godard, P ^a   Michel, F B ^a   Bousquet, J ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Cotrimoxazole; Desensitization; Drug intolerance; HIV; Protease inhibitors

Indexed keywords

COTRIMOXAZOLE; HYDROXYZINE; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC THERAPY; CONFERENCE PAPER; DESENSITIZATION; DRUG HYPERSENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PNEUMOCYSTIS PNEUMONIA;

EID: 0031968996     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(98)80059-2     Document Type: Conference Paper

References (34)

1. Coopman S.A. Johnson R.A. Platt R. Stern R.S. Cutaneous disease and drug reactions in HIV infection N. Engl. J. Med. 328 1993 1670 1674
2. Bocquet H. Chosidow O. Les toxidermies au cours du SIDA Rev. fr. Allergol. 37 1997 678 684
3. Ioannidis J.P.A. Cappeleri J.C. Skolnik P.R. Lau J. Sacks H.S. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens Arch. Intern. Med. 156 1996 177 188
4. Rieder M.J. Utrecht J. Shear N.H. Cannon M. Miller M. Spielberg S.P. Diagnosis of sulfonamide hypersensitivity reactions by in vitro « rechallengewith hydroxylamine metabolites Ann. Intern. Med. 110 1989 286 289
5. Carr A. Gross A.S. Hoskins J.M. Penny R. Cooper D.A. Acetylation phenotype and cutaneous hypersensitivity to trime-thoprim-sulphamethoxazole in HIV-infected patients AIDS 8 1994 333 337
6. Buhl R. Jaffe H.A. Holroyd K.J. Systemic glutathion deficiency in symptom free HIV-seropositive individuals Lancet 334 1989 1294 1298
7. Carrington D.M. Earl H.S. Sullivan T.J. Studies of human IgE to a sulfonamide determinant J. Allergy Clin. Immunol. 79 1987 42 447
8. Harle D.G. Baldo B.A. Wells J.V. Drugs as allergens : detection and combining site specificities of IgE antibodies to sulfamethoxazole Mol. Immunol. 25 1988 1347 1354
9. Gruchalla R.S. Sullivan T.J. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazole-poly-L-tyrosine J. Allergy Clin. Immunol. 88 1991 784 792
10. Gruchella R.S. In vitro and in vivo studies of immunologic reactivity to sulfamethoxazole J. Allergy Clin. Immunol. 85 1990 157
11. Daftarian M.P. Filion L.G. Cameron W. Conway B. Roy R. Tropper F. Diaz-Mitoma F. Immune response to sulfamethoxazole in patients with AIDS Clin. Diag. Lab. Immunol. 2 1995 199 204
12. O'Neill C.E. Reed M.A. Lopez M. Hyslop N. Guierrez E. Salvaggio J. Evaluation of immune parameters in HIV+ subjects reporting adverse reactions to sulfamethoxazole Int. Arch. Allergy Appl. Immunol. 94 1991 246 247
13. Coeshott C. Cook C. Ohnemus C. Burman W. Caraway P. Cohn D. McCall C. Sulphamethoxazole-specific antibodies in patients with AIDS: a prospective study J. Allergy Clin. Immunol. 97 1996 A656
14. Rich J.D. Sullivan T. Greineder D. Kazanjian P.H. Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons Ann. Allergy Asthma Immunol. 79 1997 409 414
15. Dintzis H.M. Dintzis R.Z. Profound specific suppression by antigen of persistent IgM, IgG, and IgE antibody production Proc. Nat. Acad. Sci. USA 89 1992 1113 1117
16. Mauri-Hellweg D. Bettens F. Mauri D. Brander C. Hunziker T. Pichler W.J. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine J. Immunol. 155 1995 462 472
17. Carr A. Vasak E. Munro V. Penny R. Cooper D.A. Immunohistochemical assessment of cutaneous drug hypersensitivity in patients with HIV infection Clin. Exp. Immunol. 97 1994 260 265
18. Schnyder B. Mauri-Hellweg D. Zanni M. Bettens F. Pichler W.J. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alpha beta T cell clones J. Clin. Invest. 100 1997 136 141
19. Hughes T.E. Almgren J.D. Mc Guffin R.W. Omoto R.J. Co-trimoxazole desensitization in bone marrow transplantation Arch. Intern. Med. 105 1986 148
20. White M.V. Haddad Z.H. Brunner E. Sainz C. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia Ann. Allergy 62 1989 177 179
21. Kletzel M. Beck S. Elser J. Shock N. Burks W. Trimethoprimsulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions AJDC 145 1991 1428 1429
22. Carr A. Penny R. Cooper D.A. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients AIDS 7 1993 65 71
23. Absar N. Daneshvar H. Beall G. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients J. Allergy Clin. Immunol. 93 1994 1001 1005
24. Bachmeyer C. Salmon D. Guérin C. Barré C. Hazebroucq G. Sicard D. Séréni D. Trimethoprim-sulphamethoxazole desensitization in HIV-infected patients: an open study AIDS 9 1995 299 312
25. Bissuel F. Cotte L. Crapanne J.B. Rougier P. Schlienger I. Trepo C. Trimethoprim-sulphamethoxazole rechallenge in 20 previously allergic HIV-infected patients after homeopathic desensitization AIDS 9 1995 407 408
26. Gluckstein D. Ruskin J. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ Clin. Inf. Dis. 20 1995 849 853
27. Nguyen M.T. Weiss P.J. Wallace M.R. Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients AIDS 9 1995 573 575
28. Picketty C. Gilquin J. Kazatchkine M.D. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients JID 172 1995 611
29. Belchi-Hernandez J. Espinosa-Parra F.J. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection Ann. Allergy Asthma. Immunol. 76 1996 355 358
30. Kalanadhabhatta V. Muppidi D. Sahni H. Robles A. Kramer M. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired human immunodeficiency syndrome Ann. Allergy Asthma Immunol. 77 1996 394 400
31. Carr A. Penny R. Cooper D.A. Allergy and desensitization to zidovudine in patients with acquired immunodeficiency syndrome (AIDS) J. Allergy Clin. Immunol. 91 1993 683 685
32. Duque S. de la Puente J. Rodriguez F. Pellon F.F. Maquicra E. Jerez J. Zidovudine-related erythroderma and successful desensitization J. Allergy Clin. Immunol. 98 1996 234 235
33. ®): allergic evaluation of a patient on combination therapy and successful oral « rushdesensitization J. Allergy Clin. Immunol. 99 1997 A1757
34. Bonfanti P. Capetti A. Riva P. Testa L. Quirino T. Hypersensitivity reactions during antiretroviral regimens with protease inhibitors AIDS 11 1997 1301 1302